Thrombocytopenia resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 31: | Line 31: | ||
==Management== | ==Management== | ||
Shown below is an algorithm summarizing the approach to thrombocytopenia. | Shown below is an algorithm summarizing the approach to thrombocytopenia. | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | |A01=A01}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | |B01=B01}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | | | |C01=CO1}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|-|v|-|-|-|.| | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | |!| | | | |!| | | | |!| | | | |!| | | |!| | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | D01 | | | D02 | | | D03 | | | D04 | | D05 | | | | | | | | |D01=D01|D02=D02|D03=D03|D04=D04|D05=D05}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | E01 | | | E02 | | | | | | | | | | | | |E01=E01|E02=E02}} | |||
{{familytree/end}} | |||
==Do's== | ==Do's== |
Revision as of 19:23, 14 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Introduction
Thrombocytopenia refers to relatively few platelets in blood. A normal platelet count ranges from 150,000 to 450,000 per microliter of blood, determined by the 2.5th lower percentile of the normal platelet count distribution.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Bone marrow suppression (for example chemotherapy, irradiation)
- Chronic alcohol use
- Chronic liver disease
- Congenital thrombocytopenia
- Disseminated intravascular coagulation
- Drug-induced thrombocytopenia
- Gestational thrombocytopenia
- HELLP syndrome
- Hemolytic uremic syndrome
- Heparin-induced thrombocytopenia
- Immune thrombocytopenic purpura
- Infections
- Preeclampsia
- Pseudothrombocytopenia
- Thrombotic thrombocytopenic purpura
Management
Shown below is an algorithm summarizing the approach to thrombocytopenia.
A01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CO1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D01 | D02 | D03 | D04 | D05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E01 | E02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Bone marrow biopsy should be done for patients that are older than 60 years of age to rule out myelodysplastic syndrome or lymphoproliferative disorders.
- Treatment should be considered for patients with platelet counts less than 30,000 per microliter.
Dont's
- Do not initiate cancer chemotherapy or antiviral therapy in the presence of thrombocytopenia.
- Do not start treatment for platelet counts greater than 50,000 per microliter unless actively bleeding.
- Don't give warfarin (coumadin) monotherapy to an acutely bleeding patient because it may induce thrombosis.